Jessica Cotrone | Investor Relations |
Simba Gill | Chief Executive Officer |
Mark Plinio | Chief Commercial Officer |
Jonathan Zung | Chief Development Officer |
Mark Bodmer | President, R&D and Chief Scientific Officer |
Vikram Purohit | Morgan Stanley |
Chris Howerton | Jefferies |
Matthew Luchini | BMO Capital |
Gobind Singh | JMP Securities |
Joe Thome | Cowen |
Good morning and welcome to Evelo Biosciences Conference Call to discuss its Second Quarter 2021 Financial Results and Business Highlights. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. At this time, I’d like to turn the call over to Jessica Cotrone of Evelo. Please proceed.
Thank you.